In particular, fatal disease was characterized by upregulated levels of IP9/CXCL11 and IP10/CXCL10, which are also expressed by microvascular endothelial cells upon activation or infection with dengue virus (41, 42), suggesting a general rather than SARS-CoV-2-specific response to viral infection. This evidence concerns the gene CXCL11 and viral infectious disease.